- Consumer Products
- Latest 79.72
- Currency US$
- Change -0.12
- Percent Change -0.15 %
- Volume 9,673,694
- Wed Mar 12, 2014 04:00 PM EDT NASDAQ data delayed 15 minutes.
12 months ended Dec 31, 2013.
Trailing 12 month results shown above.
All data is in U.S. dollars.
|Earnings||Feb 4||$0.49||May 1||$0.73|
12 months ended Mar 13, 2014.
A look at major corporate events and financial announcements that are coming up.
About the Company
Gilead Sciences, Inc. is an independent biopharmaceutical company that seeks to provide accelerated solutions for patients and the people who care for them. They have a broad-based focus on developing and marketing drugs to treat patients with infectious diseases, including viral infections, fungal infections and bacterial infections, and a specialized focus on cancer. They have expertise in liposomal drug delivery technology, a technology that the company uses to develop drugs that are safer, easier for patients to tolerate and more effective.